MENU
ASD
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

ASD stock forecast, quote, news & analysis

The investment seeks to track the total return performance, before fees and expenses, of the VettaFi Autism Impact Index (the “Index”)... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for ASD with price predictions
Nov 18, 2026

ASD's Stochastic Oscillator stoops into oversold zone

The Stochastic Oscillator for ASD moved into oversold territory on November 18, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +0.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASD advanced for three days, in 18 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 3 of 5 cases where ASD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASD as a result. In 6 of 7 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The Moving Average Convergence Divergence Histogram (MACD) for ASD turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 1 similar instances when the indicator turned negative. In 1 of the 1 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

ASD moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

ASD broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks to track the total return performance, before fees and expenses, of the VettaFi Autism Impact Index (the “Index”). Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in Autism Impact Companies. The index is designed to measure the performance of publicly traded global companies in developed markets that provide products, services and/or research supporting the autism ecosystem comprised of individuals on the autism spectrum and within the broader neurodivergent community (“Autism Impact Companies”). It is non-diversified.

Market Cap

The average market capitalization across the Defiance Autism Impact ETF (ASD) ETF is 73.91B. The market cap for tickers in the group ranges from 106.6M to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is AVXL at 106.6M.

High and low price notable news

The average weekly price growth across all stocks in the Defiance Autism Impact ETF (ASD) ETF was 8%. For the same ETF, the average monthly price growth was 11%, and the average quarterly price growth was 80%. BMRN experienced the highest price growth at 5%, while AVXL experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Defiance Autism Impact ETF (ASD) ETF was 20%. For the same stocks of the ETF, the average monthly volume growth was 32% and the average quarterly volume growth was 20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 52
Price Growth Rating: 52
SMR Rating: 67
Profit Risk Rating: 80
Seasonality Score: 23 (-100 ... +100)